GMED
Price
$87.06
Change
-$0.39 (-0.45%)
Updated
Feb 4 closing price
Capitalization
11.65B
14 days until earnings call
Intraday BUY SELL Signals
INBS
Price
$6.96
Change
-$0.46 (-6.21%)
Updated
Feb 4 closing price
Capitalization
8.38M
Intraday BUY SELL Signals
Interact to see
Advertisement

GMED vs INBS

Header iconGMED vs INBS Comparison
Open Charts GMED vs INBSBanner chart's image
Globus Medical
Price$87.06
Change-$0.39 (-0.45%)
Volume$1.72M
Capitalization11.65B
Intelligent Bio Solutions
Price$6.96
Change-$0.46 (-6.21%)
Volume$142.04K
Capitalization8.38M
GMED vs INBS Comparison Chart in %
GMED
Daily Signal:
Gain/Loss:
INBS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GMED vs. INBS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Buy and INBS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GMED: $87.06 vs. INBS: $6.95)
Brand notoriety: GMED and INBS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 119% vs. INBS: 4%
Market capitalization -- GMED: $11.65B vs. INBS: $8.38M
GMED [@Medical/Nursing Services] is valued at $11.65B. INBS’s [@Medical/Nursing Services] market capitalization is $8.38M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $188.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileINBS’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • INBS’s FA Score: 0 green, 5 red.
According to our system of comparison, both GMED and INBS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while INBS’s TA Score has 2 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 5 bearish.
  • INBS’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, GMED is a better buy in the short-term than INBS.

Price Growth

GMED (@Medical/Nursing Services) experienced а -5.19% price change this week, while INBS (@Medical/Nursing Services) price change was -23.74% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.38%. For the same industry, the average monthly price growth was -2.45%, and the average quarterly price growth was +13.17%.

Reported Earning Dates

GMED is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Medical/Nursing Services (+3.38% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($11.7B) has a higher market cap than INBS($8.38M). GMED has higher P/E ratio than INBS: GMED (28.17) vs INBS (10.17). GMED YTD gains are higher at: -0.286 vs. INBS (-27.020). GMED has higher annual earnings (EBITDA): 710M vs. INBS (-9.65M). GMED has more cash in the bank: 391M vs. INBS (1.02M). INBS has less debt than GMED: INBS (1.95M) vs GMED (119M). GMED has higher revenues than INBS: GMED (2.77B) vs INBS (3.29M).
GMEDINBSGMED / INBS
Capitalization11.7B8.38M139,635%
EBITDA710M-9.65M-7,359%
Gain YTD-0.286-27.0201%
P/E Ratio28.1710.17277%
Revenue2.77B3.29M84,143%
Total Cash391M1.02M38,333%
Total Debt119M1.95M6,096%
FUNDAMENTALS RATINGS
GMED: Fundamental Ratings
GMED
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
70
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GMEDINBS
RSI
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
65%
Bullish Trend 28 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
58%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signal:
Gain/Loss:
INBS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JXI81.940.02
+0.02%
iShares Global Utilities ETF
UYLD51.17N/A
N/A
Angel Oak UltraShort Income ETF
DRUP59.68N/A
N/A
GraniteShares Nasdaq Sel Disruptors ETF
RUSC33.23-0.06
-0.19%
Russell Inv U.S. Small Cap Equity ETF
INVG25.67-0.06
-0.23%
Gmo Systematic Investment Grade Credit ETF

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been closely correlated with SENS. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if GMED jumps, then SENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.45%
SENS - GMED
71%
Closely correlated
+1.40%
PAVM - GMED
68%
Closely correlated
+7.21%
AXGN - GMED
67%
Closely correlated
-2.81%
MOVE - GMED
66%
Loosely correlated
+4.87%
INBS - GMED
64%
Loosely correlated
-6.14%
More

INBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBS has been closely correlated with PAVM. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if INBS jumps, then PAVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBS
1D Price
Change %
INBS100%
-6.14%
PAVM - INBS
88%
Closely correlated
+7.21%
SENS - INBS
85%
Closely correlated
+1.40%
MOVE - INBS
83%
Closely correlated
+4.87%
AXGN - INBS
71%
Closely correlated
-2.81%
TCMD - INBS
70%
Closely correlated
-2.09%
More